These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4550720)

  • 1. Autoantibodies to human renal cell carcinoma.
    Ravitz G; Watne AL; Milam DF
    J Urol; 1972 Jan; 107(1):26-8. PubMed ID: 4550720
    [No Abstract]   [Full Text] [Related]  

  • 2. Human carcinoma antigens cross reacting with anti-embryonic antibodies.
    Klavins JV; Mesa-Tejada R; Weiss M
    Nat New Biol; 1971 Dec; 234(48):153-4. PubMed ID: 4332180
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro demonstration of cellular hypersensitivity to tumour antigens by means of the leucocyte migration technique in patients with renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1974 Aug; 10(8):523-31. PubMed ID: 4463002
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of tumour-directed, cell-mediated hypersensitivity detected by means of the leucocyte migration technique in patients with renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1976 Nov; 12(11):889-98. PubMed ID: 991899
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific immunofluorescence test for detection of herpesvirus antigen in cells of the Lucke renal adenocarcinoma.
    Paul SM; Mizelli M; Craige B; Blazek J; Skinner M
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):944-8. PubMed ID: 4623445
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoantibodies to human renal cell carcinoma.
    Ravitz GA; Watne AL; Milam DF
    Surg Forum; 1971; 22():516-7. PubMed ID: 5121460
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal tubular antigens in kidney tumors.
    Wallace AC; Nairn RC
    Cancer; 1972 Apr; 29(4):977-81. PubMed ID: 4335980
    [No Abstract]   [Full Text] [Related]  

  • 8. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
    Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
    Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating antibody to renal collecting ducts in patients with hepatoma or renal-cell carcinoma.
    Forbes AP; Lake JR; Bloch KJ
    Clin Exp Immunol; 1975 Dec; 22(3):426-30. PubMed ID: 178472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic evaluation of human renal cell carcinoma. In vitro studies.
    Elhilali MM; Nayak SK
    Invest Urol; 1975 Jul; 13(1):60-6. PubMed ID: 49333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.
    Cummings KB; Peter JB; Kaufman JJ
    J Urol; 1973 Jul; 110(1):31-5. PubMed ID: 4713354
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-neutrophil cytoplasmic antibody disclosing renal adenocarcinoma].
    Blanche P; Flam T; Sicard D
    Ann Med Interne (Paris); 1995; 146(4):283-4. PubMed ID: 7653955
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral cytotoxicity in human renal cell carcinoma.
    Hakala TR; Castro AE; Elliott AY; Fraley EE
    Invest Urol; 1974 Mar; 11(5):405-10. PubMed ID: 4592928
    [No Abstract]   [Full Text] [Related]  

  • 14. Discussion paper: tumor-directed cellular hypersensitivity detected by leucocyte migration in patients with renal carcinoma.
    Kjaer M; Bendixen G
    Ann N Y Acad Sci; 1976; 276():260-71. PubMed ID: 1071963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Repetitive spontaneous retrogression of metastases. A contribution on the problem of the body's own defense against tumors].
    von Salis-Samaden R
    Strahlentherapie; 1966 Jan; 129(1):26-31. PubMed ID: 5983028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Occurrence of fetorenal antigens in renal adenocarcinoma].
    Popelier G; Sion H
    Urol Int; 1977; 32(5):373-6. PubMed ID: 610032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity in patients with renal adenocarcinoma.
    Bichler KH; Ax W; Tautz C
    Eur Urol; 1975; 1(5):231-4. PubMed ID: 61119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radionuclide imaging of metastases from renal-cell carcinoma by 131I-labeled antitumor antibody.
    Belitsky P; Ghose T; Aquino J; Tai J; MacDonald AS
    Radiology; 1978 Feb; 126(2):515-7. PubMed ID: 637925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of xenogeneic antisera to a human renal cell carcinoma-associated antigen.
    Ghose T; Belitsky P; Tai J; Janigan DT
    J Natl Cancer Inst; 1979 Aug; 63(2):301-8. PubMed ID: 88535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcal protein A assay for detection of antibody directed at renal cancer cells.
    Leblanc PA; Taffet SM; Fried FA; Avis FP
    J Urol; 1979 Jun; 121(6):724-7. PubMed ID: 458941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.